News

An update from Schär regarding supply of samples and literature for healthcare professionals in light of the evolving COVID-19 situation.

This article looks to provide a brief overview of the clinical guidelines and highlight the updates that have been made in the area of gluten-related disorders.

From March 2020, Schär will be replacing its patient starter cards with coupon cards. The cards can be provided to patients embarking on a gluten-free or low FODMAP diet, providing money off their Schär purchases in supermarkets.

Dietetic group clinics have been proposed as new way to manage patients with CD with potential benefits including peer support and standardising dietetic care. This study aimed to assess the outcomes of a novel set-up of group clinics in comparison with one-to-one consultations in this patient group.

The European Commission has recently introduced new legislations that affect all FSMPs (EU Delegated Regulation 2016/128) as well as infant formulas and follow-on formulas (EU Delegated Regulation 2016/127), thus enhancing existing legislations.

This review article provides a comprehensive overview of the causes of NRCD in adults and puts forward a systematic approach to investigate and manage these patients.

As a supporter of the event Dr. Schär organised a symposium on Friday 6th September entitled ‘Patient Management in Gluten-Related Disorders: From best diagnosis to the best diet’ led by some of the world's leading specialists.

You can download the presentations here!

This review poses the question of whether it's time to consider a more tailored, ‘bottom-up’ approach to the low FODMAP diet, allowing for individualisation of dietary recommendations based on ethnicity, symptom profile, prior experience with specific foods and usual dietary intake.

A low FODMAP diet has been proposed as a therapeutic intervention for IBD patients. This study aimed to assess the effect and safety of a low FODMAP diet in this patient group over 6 weeks.